CTYCITY THERAPEUTICS, INC.
- Market cap
- $1.05B
- as of 2026-10-23
- Latest close
- $20.77
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
2 insiders bought $6.12M between Oct 19.
Under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-10-19
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ARCH Venture Partners XII, LLC | Oct 19 | Oct 19 | C | 3,294,900 | not reported | not reported | 6,013,192 | No | Form 4 |
| ARCH Venture Partners XII, LLC | Oct 19 | Oct 19 | C | 5,482,309 | not reported | not reported | 11,495,501 | No | Form 4 |
| ARCH Venture Partners XII, LLC | Oct 19 | Oct 19 | C | 2,027,006 | not reported | not reported | 13,522,507 | No | Form 4 |
| ARCH Venture Partners XII, LLC | Oct 19 | Oct 19 | P | 170,000 | $18.00 | Purchase +$3,060,000 | 13,692,507 | No | Form 4 |
| ARCH Venture Partners XII, LLC | Oct 19 | Oct 19 | C · derivative | 3,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| ARCH Venture Partners XII, LLC | Oct 19 | Oct 19 | C · derivative | 4,991,633 | $0.00 | $0 | not reported | No | Form 4 |
| ARCH Venture Partners XII, LLC | Oct 19 | Oct 19 | C · derivative | 1,845,585 | $0.00 | $0 | not reported | No | Form 4 |
| Nelsen Robert | Oct 19 | Oct 19 | C | 3,294,900 | not reported | not reported | 6,013,192 | No | Form 4 |
| Nelsen Robert | Oct 19 | Oct 19 | C | 5,482,309 | not reported | not reported | 11,495,501 | No | Form 4 |
| Nelsen Robert | Oct 19 | Oct 19 | C | 2,027,006 | not reported | not reported | 13,522,507 | No | Form 4 |
| Nelsen Robert | Oct 19 | Oct 19 | P | 170,000 | $18.00 | Purchase +$3,060,000 | 13,692,507 | No | Form 4 |
| Nelsen Robert | Oct 19 | Oct 19 | C · derivative | 3,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Nelsen Robert | Oct 19 | Oct 19 | C · derivative | 4,991,633 | $0.00 | $0 | not reported | No | Form 4 |
| Nelsen Robert | Oct 19 | Oct 19 | C · derivative | 1,845,585 | $0.00 | $0 | not reported | No | Form 4 |
| Maraganore John | Oct 19 | Oct 19 | C | 610,759 | not reported | not reported | 1,470,692 | No | Form 4 |
| Maraganore John | Oct 19 | Oct 19 | C · derivative | 500,000 | $0.00 | $0 | not reported | No | Form 4 |
| Maraganore John | Oct 19 | Oct 19 | C · derivative | 56,095 | $0.00 | $0 | not reported | No | Form 4 |
| Orth Andrew C.President & CEO | Oct 19 | Oct 19 | A · derivative | 77,979 | $0.92 | $71,741 | 77,979 | No | Form 4 |
| Nelsen Robert | Oct 15 | Oct 19 | A · derivative | 22,649 | $18.00 | $407,682 | 22,649 | No | Form 4 |
| Maraganore John | Oct 15 | Oct 19 | A · derivative | 22,649 | $18.00 | $407,682 | 22,649 | No | Form 4 |
| Nochur Sara | Oct 15 | Oct 19 | A · derivative | 22,649 | $18.00 | $407,682 | 22,649 | No | Form 4 |
| Philip Ron M | Oct 15 | Oct 19 | A · derivative | 22,649 | $18.00 | $407,682 | 22,649 | No | Form 4 |
| Greene Barry E | Oct 15 | Oct 19 | A · derivative | 22,649 | $18.00 | $407,682 | 22,649 | No | Form 4 |